Medicine and Dentistry
Psychosocial Withdrawal
90%
Receptor
60%
Social Interaction
30%
URB597
30%
Cholecystokinin
20%
Stimulation
20%
Negative Syndrome
20%
Anandamide
20%
Amygdala
20%
Prefrontal Cortex
20%
Agonist
20%
Endocannabinoid System
20%
Phencyclidine
20%
1 (2,4 Dichlorophenyl) 5 (4 Iodophenyl) 4 Methyl N (1 Piperidyl) 1h Pyrazole 3 Carboxamide
20%
Peptide
10%
Pathophysiology
10%
Chronic Drug Administration
10%
Systemic Administration
10%
Anxiogenic
10%
Rimonabant
10%
Interneuron
10%
Cholecystokinin B Receptor Antagonist
10%
Psychology
Cannabinoid
100%
Social Withdrawal
90%
Endocannabinoids
50%
Social Interaction
30%
Schizophrenia
30%
Cholecystokinin
20%
Rats
20%
Amygdala
10%
Prefrontal Cortex
10%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
60%
Schizophrenia
30%
URB597
30%
Anandamide
20%
Endocannabinoid System
20%
Phencyclidine
20%
AM251
20%
Cholecystokinin
20%
Negative Syndrome
20%
Animal
20%
Rat
20%
Systemic Administration
10%
Peptide
10%
Rimonabant
10%
Pathophysiology
10%
Cholecystokinin B Receptor Antagonist
10%
Biochemistry, Genetics and Molecular Biology
Psychosocial Withdrawal
90%
Social Interaction
30%
Animal
20%
AM251
20%
Anandamide
20%
Cholecystokinin
20%
Endocannabinoid System
20%
Phencyclidine
20%
Rat
20%
Agonist
10%
Modulation
10%
Peptide
10%
Degradation
10%
Interneuron
10%
Time
10%
Neuroscience
Eicosanoid Receptor
60%
Dementia Praecox
30%
URB597
30%
Anandamide
20%
Phencyclidine
20%
Endocannabinoid System
20%
AM251
20%
Cholecystokinin
20%
Negative Syndrome
20%
Agonist
10%
Peptide
10%
Anxiogenic
10%
Interneuron
10%